(2S)-N-[(2S,3R)-3-hydroxy-4-[2-methylpropyl-[4-(nitrosomethyl)phenyl]sulfonylamino]-1-phenylbutan-2-yl]-3,3-dimethyl-2-[3-[[2-(5-methyl-1,2-oxazol-3-yl)-1,3-thiazol-4-yl]methyl]-2-oxoimidazolidin-1-yl]butanamide

C38H49N7O7S2 — CID 91544748

IUPAC(2S)-N-[(2S,3R)-3-hydroxy-4-[2-methylpropyl-[4-(nitrosomethyl)phenyl]sulfonylamino]-1-phenylbutan-2-yl]-3,3-dimethyl-2-[3-[[2-(5-methyl-1,2-oxazol-3-yl)-1,3-thiazol-4-yl]methyl]-2-oxoimidazolidin-1-yl]butanamide
SMILESCc1cc(-c2nc(CN3CCN([C@H](C(=O)N[C@@H](Cc4ccccc4)[C@H](O)CN(CC(C)C)S(=O)(=O)c4ccc(CN=O)cc4)C(C)(C)C)C3=O)cs2)no1
InChIInChI=1S/C38H49N7O7S2/c1-25(2)21-44(54(50,51)30-14-12-28(13-15-30)20-39-49)23-33(46)31(19-27-10-8-7-9-11-27)41-35(47)34(38(4,5)6)45-17-16-43(37(45)48)22-29-24-53-36(40-29)32-18-26(3)52-42-32/h7-15,18,24-25,31,33-34,46H,16-17,19-23H2,1-6H3,(H,41,47)/t31-,33+,34+/m0/s1
InChIKeyAKHFQPZOBDOHTK-HEAIWMBWSA-N
MW779.99 g/mol
LogP5.46
Rot. Bonds17

About (2S)-N-[(2S,3R)-3-hydroxy-4-[2-methylpropyl-[4-(nitrosomethyl)phenyl]sulfonylamino]-1-phenylbutan-2-yl]-3,3-dimethyl-2-[3-[[2-(5-methyl-1,2-oxazol-3-yl)-1,3-thiazol-4-yl]methyl]-2-oxoimidazolidin-1-yl]butanamide

(2S)-N-[(2S,3R)-3-hydroxy-4-[2-methylpropyl-[4-(nitrosomethyl)phenyl]sulfonylamino]-1-phenylbutan-2-yl]-3,3-dimethyl-2-[3-[[2-(5-methyl-1,2-oxazol-3-yl)-1,3-thiazol-4-yl]methyl]-2-oxoimidazolidin-1-yl]butanamide (PubChem CID 91544748) has the molecular formula C38H49N7O7S2 and a molecular weight of 779.99 g/mol. Its IUPAC name is (2S)-N-[(2S,3R)-3-hydroxy-4-[2-methylpropyl-[4-(nitrosomethyl)phenyl]sulfonylamino]-1-phenylbutan-2-yl]-3,3-dimethyl-2-[3-[[2-(5-methyl-1,2-oxazol-3-yl)-1,3-thiazol-4-yl]methyl]-2-oxoimidazolidin-1-yl]butanamide.

Molecular Properties

Compound Name(2S)-N-[(2S,3R)-3-hydroxy-4-[2-methylpropyl-[4-(nitrosomethyl)phenyl]sulfonylamino]-1-phenylbutan-2-yl]-3,3-dimethyl-2-[3-[[2-(5-methyl-1,2-oxazol-3-yl)-1,3-thiazol-4-yl]methyl]-2-oxoimidazolidin-1-yl]butanamide
PubChem CID91544748
Molecular FormulaC38H49N7O7S2
Molecular Weight779.99 g/mol
Exact Mass779.31
IUPAC Name(2S)-N-[(2S,3R)-3-hydroxy-4-[2-methylpropyl-[4-(nitrosomethyl)phenyl]sulfonylamino]-1-phenylbutan-2-yl]-3,3-dimethyl-2-[3-[[2-(5-methyl-1,2-oxazol-3-yl)-1,3-thiazol-4-yl]methyl]-2-oxoimidazolidin-1-yl]butanamide
SMILESCc1cc(-c2nc(CN3CCN([C@H](C(=O)N[C@@H](Cc4ccccc4)[C@H](O)CN(CC(C)C)S(=O)(=O)c4ccc(CN=O)cc4)C(C)(C)C)C3=O)cs2)no1
InChIInChI=1S/C38H49N7O7S2/c1-25(2)21-44(54(50,51)30-14-12-28(13-15-30)20-39-49)23-33(46)31(19-27-10-8-7-9-11-27)41-35(47)34(38(4,5)6)45-17-16-43(37(45)48)22-29-24-53-36(40-29)32-18-26(3)52-42-32/h7-15,18,24-25,31,33-34,46H,16-17,19-23H2,1-6H3,(H,41,47)/t31-,33+,34+/m0/s1
InChIKeyAKHFQPZOBDOHTK-HEAIWMBWSA-N
XLogP5.46
TPSA178.61 Ų
H-Bond Donors2
H-Bond Acceptors11
Rotatable Bonds17
Heavy Atoms54
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 500779.99
LogP ≤ 55.46
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 1011

Analyze (2S)-N-[(2S,3R)-3-hydroxy-4-[2-methylpropyl-[4-(nitrosomethyl)phenyl]sulfonylamino]-1-phenylbutan-2-yl]-3,3-dimethyl-2-[3-[[2-(5-methyl-1,2-oxazol-3-yl)-1,3-thiazol-4-yl]methyl]-2-oxoimidazolidin-1-yl]butanamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (2S)-N-[(2S,3R)-3-hydroxy-4-[2-methylpropyl-[4-(nitrosomethyl)phenyl]sulfonylamino]-1-phenylbutan-2-yl]-3,3-dimethyl-2-[3-[[2-(5-methyl-1,2-oxazol-3-yl)-1,3-thiazol-4-yl]methyl]-2-oxoimidazolidin-1-yl]butanamide?
The IUPAC name of (2S)-N-[(2S,3R)-3-hydroxy-4-[2-methylpropyl-[4-(nitrosomethyl)phenyl]sulfonylamino]-1-phenylbutan-2-yl]-3,3-dimethyl-2-[3-[[2-(5-methyl-1,2-oxazol-3-yl)-1,3-thiazol-4-yl]methyl]-2-oxoimidazolidin-1-yl]butanamide (CID 91544748) is (2S)-N-[(2S,3R)-3-hydroxy-4-[2-methylpropyl-[4-(nitrosomethyl)phenyl]sulfonylamino]-1-phenylbutan-2-yl]-3,3-dimethyl-2-[3-[[2-(5-methyl-1,2-oxazol-3-yl)-1,3-thiazol-4-yl]methyl]-2-oxoimidazolidin-1-yl]butanamide.
What is the SMILES notation for (2S)-N-[(2S,3R)-3-hydroxy-4-[2-methylpropyl-[4-(nitrosomethyl)phenyl]sulfonylamino]-1-phenylbutan-2-yl]-3,3-dimethyl-2-[3-[[2-(5-methyl-1,2-oxazol-3-yl)-1,3-thiazol-4-yl]methyl]-2-oxoimidazolidin-1-yl]butanamide?
The canonical SMILES for (2S)-N-[(2S,3R)-3-hydroxy-4-[2-methylpropyl-[4-(nitrosomethyl)phenyl]sulfonylamino]-1-phenylbutan-2-yl]-3,3-dimethyl-2-[3-[[2-(5-methyl-1,2-oxazol-3-yl)-1,3-thiazol-4-yl]methyl]-2-oxoimidazolidin-1-yl]butanamide is Cc1cc(-c2nc(CN3CCN([C@H](C(=O)N[C@@H](Cc4ccccc4)[C@H](O)CN(CC(C)C)S(=O)(=O)c4ccc(CN=O)cc4)C(C)(C)C)C3=O)cs2)no1.
What is the InChIKey of (2S)-N-[(2S,3R)-3-hydroxy-4-[2-methylpropyl-[4-(nitrosomethyl)phenyl]sulfonylamino]-1-phenylbutan-2-yl]-3,3-dimethyl-2-[3-[[2-(5-methyl-1,2-oxazol-3-yl)-1,3-thiazol-4-yl]methyl]-2-oxoimidazolidin-1-yl]butanamide?
The InChIKey is AKHFQPZOBDOHTK-HEAIWMBWSA-N. The full InChI is InChI=1S/C38H49N7O7S2/c1-25(2)21-44(54(50,51)30-14-12-28(13-15-30)20-39-49)23-33(46)31(19-27-10-8-7-9-11-27)41-35(47)34(38(4,5)6)45-17-16-43(37(45)48)22-29-24-53-36(40-29)32-18-26(3)52-42-32/h7-15,18,24-25,31,33-34,46H,16-17,19-23H2,1-6H3,(H,41,47)/t31-,33+,34+/m0/s1.
What are the key properties of (2S)-N-[(2S,3R)-3-hydroxy-4-[2-methylpropyl-[4-(nitrosomethyl)phenyl]sulfonylamino]-1-phenylbutan-2-yl]-3,3-dimethyl-2-[3-[[2-(5-methyl-1,2-oxazol-3-yl)-1,3-thiazol-4-yl]methyl]-2-oxoimidazolidin-1-yl]butanamide?
(2S)-N-[(2S,3R)-3-hydroxy-4-[2-methylpropyl-[4-(nitrosomethyl)phenyl]sulfonylamino]-1-phenylbutan-2-yl]-3,3-dimethyl-2-[3-[[2-(5-methyl-1,2-oxazol-3-yl)-1,3-thiazol-4-yl]methyl]-2-oxoimidazolidin-1-yl]butanamide has a molecular weight of 779.99 g/mol, XLogP of 5.46, 17 rotatable bonds, 2 hydrogen bond donors, and 11 hydrogen bond acceptors.
Where does this data come from?
All data for (2S)-N-[(2S,3R)-3-hydroxy-4-[2-methylpropyl-[4-(nitrosomethyl)phenyl]sulfonylamino]-1-phenylbutan-2-yl]-3,3-dimethyl-2-[3-[[2-(5-methyl-1,2-oxazol-3-yl)-1,3-thiazol-4-yl]methyl]-2-oxoimidazolidin-1-yl]butanamide is sourced from PubChem (CID 91544748), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).